The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy

Anaesthesia

Volumn 61, Issue 12, 2006, Pages 1200-1203

  Flondor, M ^a   Merkel, M ^b   Hofstetter, C ^a   Irlbeck, M ^b   Frey, L ^b   Zwissler, B ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; MILRINONE; NITRIC OXIDE; OPTINEB IR; OXYGEN; PREDNISOLONE; PROSTACYCLIN;

ACUTE DISEASE; ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CASE REPORT; DISEASE SEVERITY; DRUG POTENTIATION; ENDARTERECTOMY; EXTRACORPOREAL CIRCULATION; FORWARD HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEMOLYTIC ANEMIA; HUMAN; HYPOXEMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; LUNG EMBOLISM; LUNG GAS EXCHANGE; MALE; PATIENT SATISFACTION; POSTOPERATIVE PERIOD; PULMONARY HYPERTENSION; THORAX SURGERY; THROMBECTOMY; THROMBOCYTOPENIA;

ADMINISTRATION, INHALATION; ADULT; ANOXEMIA; DRUG THERAPY, COMBINATION; ENDARTERECTOMY; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; NITRIC OXIDE; PULMONARY EMBOLISM; VASODILATOR AGENTS;

EID: 33750739542     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2006.04861.x     Document Type: Article

References (22)

1. Zwissler B. [Inhaled vasodilators]. Anaesthesist 2002; 51: 603-24.
2. Pepke-Zaba J, Higenbottam T, Dinh-Xuan A, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338: 1173-4.
3. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. European Journal of Clinical Investigation 1993; 23: 499-502.
4. Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicological Sciences 2001; 59: 5-16.
5. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Annals of Thoracic Surgery 1996; 62: 1759-64.
6. Imanaka H, Miyano H, Takeuchi M, Kumon K, Ando M. Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest 2000; 118: 39-46.
7. Welte M, Zwissler B, Habazettl H, Messmer K. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. European Surgical Research 1993; 25: 329-40.
8. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342: 961-2.
9. Granstrom E. The arachidonic acid cascade. The prostaglandins, thromboxanes and leukotrienes. Inflammation 1984; 8 (Suppl.): S15-S25.
10. Nagaya N, Sasaki N, Ando M, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003; 123: 338-43.
11. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. New England Journal of Medicine 2002; 347: 322-9.
12. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: Results of a European multicentric study. Intensive Care Medicine 1999; 25: 911-9.
13. Kramm T, Eberle B, Krummenauer F, et al. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy. Annals of Thoracic Surgery 2003; 76: 711-8.
14. Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. European Journal of Cardio-Thoracic Surgery 2005; 28: 882-8.
15. Langer F, Wilhelm W, Lausberg H, Schafers HJ. Iloprost and selective pulmonary vasodilation. Clinical results of intraoperative and postoperative inhalation of iloprost. Anaesthesist 2004; 53: 753-8.
16. Hill LL, Pearl RG. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension. Journal of Applied Physiology 1999; 86: 1160-4.
17. Ikeda S, Shirai M, Shimouchi A et al. Pulmonary microvascular responses to inhaled prostacyclin, nitric oxide, and their combination in anesthetized cats. Japanese Journal of Physiology 1999; 49: 89-98.
18. Rimensberger PC, Spahr S, Schopfer I, et al. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: Vasodilator capacity and cellular mechanisms. Circulation 2001; 103: 544-8.
19. Barry PW. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Anaesthesia and Intensive Care 1999; 27: 670-1.
20. Tibballs J, Goh TH, McKenzie I, Hochmann M. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Anaesthesia and Intensive Care 1999; 27: 316-7.
21. Hoeper MM, Olschewski H, Ghofrani HA, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH Study Group. Journal of the American College of Cardiology 2000; 35: 176-82.
22. Menzel M, Henze D, Soukup J, et al. Experiences with continuous intra-arterial blood gas monitoring. Minerva Anestesiologica 2001; 67: 325-31.